Keith Belk, PhD
Dr. Keith Belk is the Director of Eurofins’ Advanced Learning Institute and Professor and Holder of the Monfort Endowed Chair, Center for Meat Safety & Quality, Colorado State University (CSU), and as an Adjunct Professor in the Colorado School of Public Health. Previously, he served as Professor and Head of the Department of Animal Sciences at CSU. He earned B.S. and M.S. degrees from CSU, and a Ph.D. from Texas A&M University. He currently serves in a consulting role as the Director of Education for Eurofins Rapid Microbiology Laboratories, LLC. Dr. Belk is also a member of the International Committee for the National Western Stock Show, the Board of Directors for the International Stockmen’s Educational Foundation, on the Academic Advisory Committee for the Meat Institute Protein PACT, and on the technical advisory committees for Sustainable Beef, JBS, Colorado Premium Foods, and Hawkins.
Below are resources from Dr. Keith Belk:
Innovation in the nutraceutical and functional food space is accelerating, but commercialization is struggling to keep pace. The conversation is shifting from “What can we formulate?” to a much harder question:
“What will actually work in a factory, at scale, for 12+ months?” Here are the biggest takeaways from Vitafoods Europe 2026.
For brands involved in pet food product development, 2025 has been a year of acceleration. Looking ahead to 2026, formulation complexity and commercialization risk will only increase. New trends are shaping the future of pet nutrition. Keep reading to learn more about what they mean for R&D, manufacturing, and regulatory strategy.
Per- and polyfluoroalkyl substances (PFAS) have become a growing focus for regulators, manufacturers, and consumers alike especially when it comes to foods intended for vulnerable populations such as infants. Learn about the importance of proactive PFAS testing and how Eurofins can help here.
Explore Eurofins Rapid Microbiology Laboratory's BSL‑2 pilot plant for dried and fermented meat validation studies, from fermentation chambers to HPP and final product results.
Explore how rapid testing—from culture methods to PCR and droplet digital PCR—is transforming STEC detection and speeding food safety decisions.
As the U.S. moves toward record biofuel integration, producers face growing pressure to validate biobased fuel quality, strengthen their testing programs, and stay ahead of new regulatory expectations. Learn how Eurofins QTA is adjusting to new requirements.
Have questions about the Eurofins’ Infant Formula Contaminant Certification or Eurofins Protocol 102? Check out our guide for the answers to frequently asked questions regarding this type of certification.
The United States Pharmacopeia (USP) is rolling out important updates to General Chapters <2021> and <2022> and, taking effect on April 1, 2026. For manufacturers who rely on microbiological testing to ensure product quality and regulatory compliance, understanding what’s changing and what actions are required is essential.
Important upcoming updates to USP Chapters <2021> and <2022 went into effect on April 1, 2026. These changes modify several microbiological testing requirements, including incubation times, suitability testing, and enrichment steps for specific organisms. Check out our answers to frequently asked questions about the updates.
Why do food companies wait for recalls instead of investing in advanced foreign object detection? A candid take on proactive food safety and ROI.
